Minerva Neurosciences, Inc.
NERV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $12 | $15 | $17 | $21 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $0 | $1 | $1 |
| Total Curr. Assets | $13 | $16 | $18 | $22 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $15 | $15 | $15 | $15 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $15 | $15 | $15 | $15 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $28 | $30 | $33 | $37 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $1 | $2 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2 | $2 | $1 | $1 |
| Total Curr. Liab. | $3 | $3 | $2 | $3 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $60 | $60 | $60 | $60 |
| Total NC Liab. | $60 | $60 | $60 | $60 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $63 | $63 | $62 | $63 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$405 | -$402 | -$399 | -$395 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $371 | $370 | $370 | $370 |
| Total Equity | -$35 | -$32 | -$29 | -$26 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $28 | $30 | $33 | $37 |
| Net Debt | -$12 | -$15 | -$17 | -$21 |